Are SNRIs more effective than SSRIs? J Psychopharmacol. 2013 Aug.

01.08.2013

Only one third of patients prescribed SSRI s achieve full remission. Are dual reuptake inhibitors  ( SNRIs:  nor adrenaline and serotonin) better than SSRIs?. When medications differ in efficacy by modest degrees only, it is difficult to show the difference unless you have very large trials. Metaanalysis and systemtic review of these metaanalysis offer an opportunity to look at this question closely.

Andrew J Bradley and Alan J Lenox-Smith reviewed comparison trials of  SSRis against the SNRIs in acute treatment of deprsssion (duloxetine, desvenlafaxine, milnacipran and venlafaxine). They systematically reviewed the meta analysis reports and pragmatic trials of significance.

Findings

49 efficacy-related meta-analyses were identified.  Fifteen meta-analyses were with summary data   and seven meta-analyses provided  individual patient data.

Venlafaxine:  Venlafaxine was consistently found to be superior in remission rates compared to pooled SSRIs with OR for remission ranging from 1.12–1.43. Pragmatic trials  like STAR D showed remission rates of 17.6% for sertraline and 24.8% for venlafaxine XR at level 2 treatment ( ie after first line ,citalopram). This difference was not statistically significant.ARGO study  (open-label, randomised, multicentre study comparing the efficacy of venlafaxine XR and ‘conventional antidepressants’  in conventional non-responders) showed that patients treated with venlafaxine XR had a statistically significant superior rate of remission compared with those receiving CAs (which included mirtazapine) (59% vs 51%; p<0.0001)

Duloxetine:  RCT summary-level meta-analyses and two patient-level meta-analyses comparing duloxetine with SSRIs met  inclusion criteria .A remission rate in favour of duloxetine was found OR 1.1≥1 (95% CI 0.91–1.34) from the analysis of summary data from nine RCTs but this was not statistically significant .The benefit was not staistically significant against paroxetine,  fluoxetine or citolapram. One pragmatic trial that was included also did not find significant benefits.

Desvenlafaxine: No meta-analysis of any type or any pragmatic studies was found comparing desvenlafaxine with SSRIs.

Conclusions:

Data comparing venlafaxine to pooled SSRIs was consistently supportive of increased efficacy of dual reuptake inhibition in both remission and response rates .Venlafaxine showed superior efficacy compared to fluoxetine and paroxetine  and was generally in favour of venlafaxine when compared to fluvoxamine and sertraline. With citalopram results were equivocal.Mixed results from the existing data mean a definitive conclusion regarding additional efficacy of the addition of NA reuptake inhibition to that of 5-HT cannot currently made.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s